The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global gummy vitamins market reached a value of US$6.4 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$8.6 Billion by 2027, exhibiting at a CAGR of 5.31% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Gummy vitamins are chewable nutraceuticals with a texture and taste similar to gummy candies. They are available in a wide variety of flavors, sizes, shapes and colors and are consumed to fulfill the nutritional requirements of both adults and children. They are manufactured using corn starch, sugar, gelatin, water, fruit-based flavors and added colorings. These vitamins are used to increase the intake of specific nutrients, such as calcium, iron, magnesium and vitamin A, B, C, D and E. They are usually stored and distributed in bottles, jars and pouches. In comparison to the traditionally used tablets, capsules and pills, gummy vitamins are easy to swallow, digest and absorb in the body.
Significant growth in the nutraceutical industry across the globe is one of the key factors creating a positive outlook for the market. Moreover, rising health consciousness among the masses, along with increasing awareness regarding the benefits of regular consumption of dietary supplements to maintain a healthy lifestyle, is providing a thrust to the market growth. With the escalating instances of nutritional deficiencies and undernourishment among children and adults, there is a shifting preference toward gummy vitamins to prevent chronic diseases and maintain physical and mental wellbeing. In line with this, the widespread adoption of Vitamin C supplements to boost immunity against the coronavirus (COVID-19) infection is also contributing to the growth of the market. Various product innovations, such as the launch of gummy vitamins in novel flavors, such as apple, orange, pineapple, strawberry, lime, cola and cherry, using natural and organic ingredients, are acting as other growth-inducing factors. Manufacturers are also providing vitamins that include customized nutrient composition specialized for each consumer. Other factors, including rising expenditure capacities of the consumers, along with extensive research and development (R&D) activities, are anticipated to drive the market toward growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global gummy vitamins market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on type, demographics and sales channel.
Breakup by Type:
Breakup by Demographics:
Breakup by Sales Channel:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Bayer AG, Bettera Wellness LLC, Church & Dwight Co. Inc., Hero Nutritionals, Ion Labs Inc. (DCC plc), Nature's Way Products LLC. (Dr. Willmar Schwabe GmbH & Co. KG), Pfizer Inc., Pharmavite (Otsuka Pharmaceutical Co. Ltd), Santa Cruz Nutritionals, SmartyPants Vitamins (Unilever plc), The Honest Company Inc. and Vitakem Nutraceutical Inc.
|Base Year of the Analysis||2021|
|Segment Coverage||Type, Demographics, Sales Channel, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Bayer AG, Bettera Wellness LLC, Church & Dwight Co. Inc., Hero Nutritionals, Ion Labs Inc. (DCC plc), Nature's Way Products LLC. (Dr. Willmar Schwabe GmbH & Co. KG), Pfizer Inc., Pharmavite (Otsuka Pharmaceutical Co. Ltd), Santa Cruz Nutritionals, SmartyPants Vitamins (Unilever plc), The Honest Company Inc. and Vitakem Nutraceutical Inc.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at